EFPIA Official Prods Japan to Limit CEA Application to Financially Impactful Drugs

March 19, 2019
Yasuko Aitoku, Chair, Access Committee, EFPIA Japan Yasuko Aitoku, chair of the European Federation of Pharmaceutical Industries and Associations (EFPIA) Japan’s Access Committee, on March 18 offered proposals on how Japan should operate its soon-to-launch cost-effectiveness assessment (CEA) system, urging...read more